Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2037

Annual patent cliff calendar for 2037 — US pharmaceutical patents by expiration date.

Patents
1,615

Quick answer

1,615 indexed pharmaceutical patents have expiration dates in 2037. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 9775876

    Compositions and methods for CaMKII inhibitors and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Tue Oct 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9775911

    Composition comprising a polymeric reagent

    Nektar Therapeutics · Granted Tue Oct 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9782464

    Methods and compositions for inhibiting diseases of the central nervous system

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9783578

    Immunosuppression modulating compounds

    Aurigene Discovery Technologies Limited · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9782382

    TOFA analogs useful in treating dermatological disorders or conditions

    Dermira (Canada), Inc. · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9782488

    Oligomer-beta blocker conjugates

    Nektar Therapeutics · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9782428

    Method for generation of broadly neutralizing anti-pathogen antibodies

    Northwestern University · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9782437

    Methods and compositions for targeted cleavage and recombination

    Sangamo Therapeutics, Inc. · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9783595

    Neutralizing GP41 antibodies and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9783586

    Inhibitors of the linear ubiquitin chain assembly complex (LUBAC) and related methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9783590

    Variants of human taste receptor genes

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9783550

    Highly potent inhibitors of porcupine

    The Board of Regents of the University of Texas System · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9783515

    Radiomitigating pharmaceutical formulations

    The Regents of the University of California · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9783858

    Altered microbiome of chronic pelvic pain

    Northwestern University · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9783525

    Map kinase modulators and uses thereof

    Northwestern University · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9783501

    Substituted quinolines as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9782480

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9782479

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9782478

    Prostate-specific membrane antigen binding proteins and related compositions and methods

    Aptevo Research and Development LLC · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9782472

    Therapeutic compositions and methods for treating HIV including identification and manipulation of particular domains associated with immunogenicity

    The Regents of the University of California · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9782465

    Serologic correlates of protection against Bacillus anthracis infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9783572

    Synthesis of syrbactin proteasome inhibitors

    The Regents of the University of California · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9782430

    Resorbable oxidized cellulose embolization solution

    Covidien LP · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9782399

    Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen receptor function and methods of using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9783598

    Compositions and methods for treating and preventing Staphylococcus aureus infections

    XBIOTECH INC. · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9782408

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9782347

    Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract

    The Regents of the University of California · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9782402

    Injectable composition comprising buprenorphine

    Indivior UK Limited · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9782345

    Ocular composition and method

    Jade Therapeutics, Inc. · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9782381

    Molecular targets for healing or treating wounds

    University College Cardiff Consultants Limited · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9782387

    Compositions and methods for treating hematological malignancies

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9782258

    Intramyocardial patterning for global cardiac resizing and reshaping

    The Regents of the University of California · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9783616

    Regulating transplant rejection of donor and embryonic stem cell-derived tissues and organs

    UNIVERSITY OF CONNECTICUT · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9783579

    Compositions and methods for dengue virus chimeric constructs in vaccines

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9783529

    Pyridazinone compounds and methods for the treatment of cystic fibrosis

    Flatley Discovery Lab, LLC · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9783507

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9782416

    Pharmaceutical formulations of potassium ATP channel openers and uses thereof

    ESSENTIALIS, INC. · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9782398

    Pharmaceutical compositions comprising an antipsychotic drug and a VMAT2 inhibitor and uses thereof

    Neurocrine Biosciences, Inc. · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9782357

    RNAi molecule delivery platform based on single-siRNA and shRNA nanocapsules

    The Regents of the University of California · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9782337

    Methods and compositions using compounds from fetal cells and tissues to improve condition of skin

    The Regents of the University of California · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9783596

    Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephalitis virus (JEV) and their use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9783806

    TMPRSS6 iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9783788

    Porcine pseudorabies virus (PRV)-YF strain and its application

    SOUTH CHINA AGRICULTURAL UNIVERSITY · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9783787

    Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9783855

    Cancer screening by detection of ultrastructural and molecular markers

    Northwestern University · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9783827

    DNA-binding proteins and uses thereof

    Sangamo Therapeutics, Inc. · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9790215

    Pyridazinone compounds and methods for the treatment of cystic fibrosis

    Flatley Discovery Lab, LLC · Granted Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9790273

    Anti-HLA-B*27 antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2037?

1,615 published patents in our USPTO index have expiration dates falling in calendar year 2037.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.